Literature DB >> 8723236

Evaluation of various oral antimicrobial formulations for eradication of Helicobacter hepaticus.

C J Foltz1, J G Fox, L Yan, B Shames.   

Abstract

Helicobacter hepaticus colonizes the cecum and colon of several strains of mice from a variety of commercial suppliers, persistently infects mice, causes chronic hepatitis, is linked to hepatic tumors in A/JCr mice, and has been associated with inflammatory bowel disease of athymic and scid mice. For this reason, eradication of the organism from infected mouse colonies is desirable. We recently reported that amoxicillin or tetracycline-based triple therapy (amoxicillin or tetracycline in combination with metronidazole and bismuth) given by oral gavage 3 times daily for 2 weeks eradicated H. hepaticus in 8- to 10-week-old A/JCr mice. To establish a more convenient therapy regimen for eradicating H. hepaticus, we evaluated water and dietary administration of various antibiotic combinations in A/JCr and DBA/2 mice naturally infected with H. hepaticus. The A/JCr male mice received amoxicillin-based triple therapy in drinking water or by oral gavage, or received tetracycline-based triple therapy in the drinking water. The DBA/2J female mice received amoxicillin-based triple therapy in a specially formulated dietary wafer or by oral gavage, or received enrofloxacin in drinking water. All treatments were given for a 2-week period. Control animals received no treatment. One month after treatment, H. hepaticus was recovered from the liver, cecum, or colon of A/JCr control mice and mice receiving amoxicillin- or tetracycline-based triple therapy in drinking water but not in mice receiving amoxicillin-based triple therapy by oral gavage. Helicobacter hepaticus was not recovered from DBA/2J mice receiving amoxicillin-based triple therapy in dietary wafer or by oral gavage but was recovered from control mice and 7 of 10 mice receiving enrofloxacin in drinking water. Results indicate that amoxicillin-based triple therapy administered in the diet or by oral gavage is effective in eradicating H. hepaticus. Antibiotics administered in the water, however, were not effective in eradicating the organism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723236

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  10 in total

1.  Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D.

Authors:  Maria Del Carmen Martino-Cardona; Sarah E Beck; Cory Brayton; Julie Watson
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-05       Impact factor: 1.232

Review 2.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus.

Authors:  J G Fox; L Yan; B Shames; J Campbell; J C Murphy; X Li
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

4.  Antibiotic administration alters the community structure of the gastrointestinal micobiota.

Authors:  Courtney J Robinson; Vincent B Young
Journal:  Gut Microbes       Date:  2010-05-24

Review 5.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

6.  Results of Survey Regarding Prevalence of Adventitial Infections in Mice and Rats at Biomedical Research Facilities.

Authors:  James O Marx; Diane J Gaertner; Abigail L Smith
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

7.  The use of cross-foster rederivation to eliminate murine norovirus, Helicobacter spp., and murine hepatitis virus from a mouse colony.

Authors:  James E Artwohl; Jeanette E Purcell; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-11       Impact factor: 1.232

8.  Effects of medicated diet to eradicate Helicobacter spp. on growth, pathology, and infection status in Rag1-/- and nude mice.

Authors:  Caroline M Garrett; Dillon Muth; Julie Watson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-05       Impact factor: 1.232

9.  The effects of intestinal microbial community structure on disease manifestation in IL-10-/- mice infected with Helicobacter hepaticus.

Authors:  Nabeetha A Nagalingam; Courtney J Robinson; Ingrid L Bergin; Kathryn A Eaton; Gary B Huffnagle; Vincent B Young
Journal:  Microbiome       Date:  2013-05-10       Impact factor: 14.650

Review 10.  Helicobacter hepaticus, a new pathogenic species of the Helicobacter genus: Similarities and differences with H. pylori.

Authors:  Tahereh Falsafi; Mohaddese Mahboubi
Journal:  Iran J Microbiol       Date:  2013-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.